Blue Matter Blog

Diversity, Equity, and Inclusion: Core to Our “People First” Culture
October 30, 2020

If you’ve been reading the various articles in our “People First” series, you’ve no doubt learned that fostering an open, inclusive, and diverse environment is ingrained in our culture.  It’s one of our core values and we hold ourselves accountable by including it in our regular Values Survey, which you can learn more about here. …

Success in Rare Diseases, Part III: Continuous Evidence Generation in the Rare Disease Ecosystem
October 26, 2020

In Parts 1 and 2 of our series, we introduced the rare disease (RD) ecosystem as a uniquely interrelated set of stakeholders and discussed the key challenges and considerations for successful RD clinical trials. We focused on (pre)registrational clinical trial design, but of course regulatory approval does not mark the end of evidence generation. Here …